Product Information

AMLODIPINE-OLMESARTAN 10-40 MG is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.3424 per EA under NDC 31722044830. Its NADAC has been published 40 times since Sep 24, 2025.

The Low Outlier badge above means this manufacturer's average price in the Amlodipine and Olmesartan Medoxomil market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

AMLODIPINE-OLMESARTAN 10-40 MG

Amlodipine and Olmesartan Medoxomil
$0.3424per EA
Low Outlier

Strength

10; 40 mg/1; mg/1

NDC

31722044830

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

6/17/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA209591

On Market Since

2/14/2025

Pharmacological Classes

Angiotensin 2 Receptor Antagonists
Angiotensin 2 Receptor Blocker
Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A Inhibitors
Dihydropyridine Calcium Channel Blocker
Dihydropyridines

Price Statistics

The NADAC for AMLODIPINE-OLMESARTAN 10-40 MG has been published 40 times since Sep 24, 2025, and over the history we have for it it has risen 4.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3424 per EA
All-time high$0.3615 (Mar 11, 2026)
All-time low$0.3156 (Oct 22, 2025)
52-week high$0.3615
52-week low$0.3156
Median price$0.3410
Average price$0.3407
Largest weekly change+7.2% (Dec 17, 2025)
Weeks tracked40
Tracking sinceSep 24, 2025

Price History

1W

0.0%

1M

+0.4%

3M

-3.0%

6M

+0.5%

1Y

N/A

3Y

N/A

5Y

N/A

All

+4.9%

Generic Alternatives

The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of AMLODIPINE-OLMESARTAN 10-40 MG?

The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-OLMESARTAN 10-40 MG, manufactured by Camber Pharmaceuticals Inc., is $0.3424 per EA (NDC 31722044830), effective Jun 24, 2026.

How has the price of AMLODIPINE-OLMESARTAN 10-40 MG changed over time?

Over the history we have for it, the NADAC for AMLODIPINE-OLMESARTAN 10-40 MG has risen 4.9%. It has been tracked across 40 weekly CMS publications since Sep 24, 2025.

What are the highest and lowest recorded NADAC prices for AMLODIPINE-OLMESARTAN 10-40 MG?

Since Sep 24, 2025, the NADAC for AMLODIPINE-OLMESARTAN 10-40 MG has ranged from a low of $0.3156 (Oct 22, 2025) to a high of $0.3615 (Mar 11, 2026), with a median of $0.3410 per EA.

Are there cheaper alternatives to AMLODIPINE-OLMESARTAN 10-40 MG?

5 NADAC-published products share the same active ingredient, strength, and dosage form as AMLODIPINE-OLMESARTAN 10-40 MG, but none are currently priced below it.

Who manufactures AMLODIPINE-OLMESARTAN 10-40 MG?

AMLODIPINE-OLMESARTAN 10-40 MG (NDC 31722044830) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.